Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 368

Similar articles for PubMed (Select 11786451)

1.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration.

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

3.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
4.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

5.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

6.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
8.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee.

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

9.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

11.

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

Sudlow CL, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001246. doi: 10.1002/14651858.CD001246.pub2. Review.

PMID:
19821273
12.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Keller TT, Squizzato A, Middeldorp S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD005158.

PMID:
17636787
13.
14.
15.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001820. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001820.

PMID:
16625549
16.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001820. Review.

PMID:
17636684
17.
18.

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A.

Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.

19.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Review.

PMID:
22161375
20.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC.

Cochrane Database Syst Rev. 2004;(3):CD003186. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD003186.

PMID:
15266473
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk